Insulet

OmniPod | A convenient way to help manage diabetes.

Launch date

2000

Employees

1001-5000 people

Market cap

Enterprise valuation

€15.2b (Public information from Sep 2024)

Acton Massachusetts (HQ)

http://insulet.com

https://twitter.com/myomnipod https://www.facebook.com/omnipod https://www.linkedin.com/company/insulet-corporation

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	904m	1.1b	1.3b	1.7b	2.0b	2.4b	2.8b
% growth	23 %	21 %	19 %	30 %	19 %	18 %	18 %
EBITDA	54.8m	124m	36.5m	324m	424m	520m	638m
% EBITDA margin	6 %	11 %	3 %	19 %	21 %	22 %	23 %
Profit	6.8m	16.8m	4.6m	206m	379m	286m	365m
% profit margin	1 %	2 %	-	12 %	19 %	12 %	13 %
EV / revenue	18.7x	17.1x	16.2x	9.3x	7.3x	6.0x	5.0x
EV / EBITDA	309.3x	151.6x	580.0x	49.0x	34.6x	27.7x	22.0x
R&D budget	147m	160m	180m	205m	-	-	-
R&D % of revenue	16 %	15 %	14 %	12 %	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Jan 2000	Prism Venture Management	$1.0m	Seed
Feb 2001	Prism Venture Management	$980k	Series A
Mar 2004	Alta Partners Prism Venture Management SightLine Partners Versant Ventures SV Health Investors TIAA MedVenture Associates Oakwood Medical Investors	$35.5m	Series D
Feb 2006*	Alta Partners Prism Venture Management Schroders OrbiMed Versant Ventures	$50.0m	Late VC
Jan 2007	Alta Partners Prism Venture Management SightLine Partners Red Abbey Venture Partners Aphelion Capital OrbiMed Versant Ventures SV Health Investors Longitude Capital MedVenture Associates	$50.9m	Series E
May 2007	N/A	N/A	IPO
Dec 2023*	Portside Wealth Group	$3.4m	Post IPO Equity
Total Funding		€126m

Tech stackLearn more about the technologies and tools that this company uses.

Neighborhood Diabetes

ACQUISITION by Insulet Jun 2011